Santa Clara, CA, United States of America

Fiona A Harding

USPTO Granted Patents = 26 

 

 

Average Co-Inventor Count = 1.9

ph-index = 7

Forward Citations = 209(Granted Patents)


Location History:

  • Santa Clara, CA (US) (2001 - 2016)
  • Mountain View, CA (US) (2016 - 2020)

Company Filing History:


Years Active: 2001-2020

Loading Chart...
Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents

Title: **Fiona A Harding: Innovator in Therapeutic Antibodies**

Introduction

Fiona A Harding is a distinguished inventor based in Santa Clara, CA, recognized for her significant contributions to the field of biotherapeutics. With a remarkable portfolio of 26 patents, her work is pivotal in the development of innovative treatments leveraging antibody technology.

Latest Patents

Fiona's latest patents showcase her expertise in creating novel molecular solutions. One of her patents includes "Anti-PD-1 Antibodies and Their Uses," offering groundbreaking insights into new anti-PD-1 antibodies, compositions utilizing these antibodies, as well as the nucleic acids encoding them. Another notable patent is titled "Anti-OX40 Antibodies and Their Uses," which provides significant advancements through the introduction of novel anti-OX40 antibodies along with their applications, compositions, and methods for use.

Career Highlights

Throughout her career, Fiona A Harding has worked with renowned organizations such as Genencor International, Inc. and AbbVie Biotherapeutics, Inc. Her experience at these leading biopharmaceutical companies has equipped her with the expertise to drive innovations in antibody therapies effectively.

Collaborations

Collaboration is a key aspect of innovation, and Fiona has worked alongside esteemed colleagues such as David Aaron Estell and Yoshiko Akamatsu. These partnerships enhance her research and contribute to the successful development and commercialization of new biotherapeutic solutions.

Conclusion

Fiona A Harding’s impressive track record of patents and collaborations marks her as a leading figure in the biotechnology space. Her ongoing commitment to innovation in therapeutic antibodies will continue to influence the future of biomedicine positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…